Bactiguard Holding Ab · OMXSTO:BACTI_B
Bactiguard Holding Ab — Berenberg Pan-European Discovery Conference 2023
16 slides from Bactiguard Holding Ab's conference presentation, Jun 15, 2023
Slide 1: Introducing Bactiguard
Introducing Bactiguard Berenberg Pan-European Discovery Conference – 15th - 16th June 2023 – Portugal “preventing infections” Christian Kinch Chairman of the Board
Slide 2: Hospital acquired infections
Hospital acquired infections HAI frequency ”HAI is the 3rd largest 1 in every 10 patients worldwide cause of death after affected by hospital acquired infections cancer & cardiovascular disease!!!” • >20 million infected • >10 million annual deaths by • >4,5 million deaths 2050
Slide 3: Bactiguard
Bactiguard By getting out of bed every single day - Bactiguard: Reduce the use of antibiotics –> prevent spread of multi-resistant bacteria Reduce healthcare cost Save lives 3
Slide 4: What does HAI look like when getting personal?
What does HAI look like when getting personal? 4
Slide 5: We prevent 15 000 cases as Shahrzad's every year
We prevent 15 000 cases as Shahrzad’s every year 5
Slide 6: Antibiotic use in Europe
Antibiotic use in Europe Netherlands Penicillins (J01C) Estonia Latvia Cephalosporins and other beta-la Romania Tetracyclines (J01A) Germany Macrolides, lincosamides and streptogramins (J01F) Sweden Slovenia Quinolones (J01M) Austria Sulfonamides and trimethoprim (J01E) Hungary Other J01 Classes Nor
Slide 7: AMR in the EU
AMR in the EU <1% 1%- <5% 5%- <10% 10%- <25% 25%- <50% >50% No data reported or less than 10 isolates Not included Liechtenstien Luxemburg Malta Källa: ECDC 7
Slide 8: Prevalence of healthcare associated infections
Prevalence of healthcare associated infections The most frequent adverse event in the healthcare *Sweden 9% Canada 11,6% EU average ~7% USA 4,5% Turkey 12,5% Iraq ~20% Tanzania 15% Brazil 14% New Zeeland 12% Source: WHO/Patient Safety/Report on the Burden of Endemic Healthcare associated infection w
Slide 9: Continuously strengthening clinical evidence
Continuously strengthening clinical evidence More applications and markets covered • >240 million patients treated with Bactiguard coated catheters • No reported adverse events associated with the coating • Over 40 clinical studies including more than 100,000 patients • 42% weighted average reductio
Slide 10: A global innovative medtech company with Swedish roots
A global innovative medtech company with Swedish roots Vision: to champion a healthier world by preventing infections • Effective, safe/biocompatible • License partnerships with global • Around 210 employees and user-friendly technology leading medtech companies and solutions for infection preventio
Slide 11: Opportunities behind critical global healthcare trends
Opportunities behind critical global healthcare trends “not a question of if, it’s a question of when” The issues The USD 80bn market opportunity • Rise of infections, increased antibiotics use and Orthopedics 40 development of multi-resistant bacteria a threat to global health and modern medicine U
Slide 12: Rolling 12-month revenues
Rolling 12-month revenues Strong overall momentum – rolling RTM development, MSEK 12-month revenues all-time high 80,0 250 60,0 • Blue bar license revenues – key 200 driver is BD and initial contributions from Zimmer Biomet (trauma) 40,0 150 • Yellow bar new license revenues – good momentum in both
Slide 13: Drivers to deliver growth and profitability
Drivers to deliver growth and profitability The need for infection prevention has never been greater Illustrative M&A Financial targets 2026 Revenues >1 billion SEK o foli EBITDA >400 million SEK rt uct po d n pro Ow * customers e Today new licens Future Orthopedics (broader portfolio) Existing lice
Slide 14: Key priorities 2023
Key priorities 2023 Focus on growth and transformation Strengthen Technology – license business – drive and develop BPP – current and new partners coating, current and new operational excellence US go-to-market Continued focus on strategy FDA-approvals 14
Slide 15: Why invest in Bactiguard?
Why invest in Bactigard? To champion a healthier world by preventing infections • Part of solving some serious global health challenges • Major market potential behind critical global healthcare trends • Effective, safe/biocompatible and user-friendly solutions for preventing infections • Focused gr
Slide 16: Bactiguard on the outside – safe on the inside
Bactiguard – The company Bactiguard on the outside – safe on the inside 16 |
Bactiguard — Berenberg Pan-European Discovery Conference 2023 on 6ix